For today onwards ThePharmaDispatch will be sent daily -- covering the five most interesting developments.

Do let us know if you prefer this new format or prefer it being sent just once a week: [email protected]. Thank You!

In this issue:

1. How China has jumped out in front of the US for genome-editing clinical trials with CRISPR

2. Hospitals to launch generic drug company

3. New hopes for a cancer blood test?

4. Brexit blowback

5. Vinod Khosla's thoughts on Reinventing Health

China Races Ahead in Gene-Editing Trials

U.S. scientists helped devise the CRISPR biotechnology tool. First to test it in humans are Chinese doctors.

via The Wall Street Journal

Hospitals to Launch Generic Drug Company

Four not-for-profit hospital systems that own 10% of U.S. hospitals — Intermountain Healthcare, Ascension, SSM Health and Trinity Health — are banding together to create a new generic drug company. The Department of Veterans Affairs also is helping and has expressed interest as a purchaser.

via Official Press Release

New Hopes for a Cancer Blood Test

A new study is fueling optimism about developing a blood test which can detect cancers, according to a new report published in the journal Science. There's still a long way to go before a "liquid biopsy" becomes reality and nixes the need for intrusive, expensive tests that involve removing actual tissue; but the experimental test can reportedly detect eight common cancers (including lung, breast, colon, pancreas, and liver cancer) and identify where they're from in the body.

via NPR

Brexit Blowback

MPs warned the UK could face a cancer treatment crisis if supplies of radioactive material were hit once the UK leaves Euratom, the EU nuclear regulator. Doctors continue to agitate against Brexit, arguing that medical research is a net beneficiary of EU grants and would suffer without access to EU-powered trials. The debate over Brexit freeing up funds for the NHS has intensified.

via Telegraph and BMJ

Reinventing Health

Investor and entrepreneur Vinod Khosla discusses how all aspects of medicine, from drug discovery to disease detection, will be disrupted with data science and AI.

Read his short blog post on Medium